U.S. Metals and Mining Stock News

Wondering if ANI Pharmaceuticals is still good value after its big run, or if you might be late to the party? You are in the right place to break down what the current price really implies. The stock has cooled slightly in the short term, with the share price down 1.7% over the last week and 4.3% over the past month. It is still up 45.0% year to date and 42.1% over the last year, and a huge 111.2% and 157.9% over the past 3 and 5 years respectively. Recent attention around ANI...

In its recently reported Q3 2025 results, ConocoPhillips beat analyst expectations, raised full-year production guidance, and lowered operating cost guidance, signaling stronger-than-anticipated operational performance. Alongside this, the company stood out in U.S. shale by improving Delaware Basin well productivity in 2025, even as peers generally faced softer results and productivity concerns. With ConocoPhillips increasing full-year production guidance despite sector-wide supply risks,...

AerCap Holdings N.V. recently authorized a share repurchase program of up to US$1,000 million through June 30, 2026, alongside new leasing deals and the first delivery of a Boeing 777-300ERSF freighter to Fly Meta Leasing. Together, the sizeable buyback and expanding freighter and narrowbody leasing activity highlight AerCap’s ongoing focus on capital returns and strengthening its position in the cargo segment. We’ll now explore how AerCap’s US$1,000 million share repurchase authorization...

Autodesk stock steadies as long term performance diverges Autodesk (ADSK) shares have cooled off recently, with the stock down over the past 3 months even as the company continues to grow revenue and earnings at a healthy double digit clip. See our latest analysis for Autodesk. Over the past year, Autodesk’s share price return has been roughly flat while its three year total shareholder return of about 55% still speaks to solid long term momentum. This suggests recent weakness reflects cooler...

Protagonist Therapeutics (PTGX) shares are back on traders radar after the company and partner Takeda highlighted 52 week Phase 3 VERIFY data for rusfertide in polycythemia vera ahead of an ASH oral presentation. See our latest analysis for Protagonist Therapeutics. The VERIFY update lands on top of a powerful run, with the share price now at $95.35 after a 63.33% 3 month share price return and a huge 3 year total shareholder return of 882.99%. This suggests momentum and expectations are...

If you are wondering whether Tyler Technologies is still worth its premium price tag or if the recent pullback is opening up a genuine opportunity, this breakdown will help you figure out whether the current share price makes sense. The stock is down about 2.9% over the last week, 2.6% over the last month, and roughly 20.7% year to date. This extends a 25.5% slide over the past year, although it remains up 42.3% over three years. Much of this cooling off has come after a strong multi year...

If you are wondering whether ACM Research is still a smart buy after its huge run, or if you might be late to the party, this breakdown will help you decide with a clear, valuation-first lens. The stock has surged recently, climbing 10.6% over the last week, 23.2% over the past month, and a striking 149.4% year to date. Moves like this often signal that market expectations and perceived risk are shifting fast. Those moves have come as investors stay focused on ACM Research's role in...

If you are wondering whether Hartford Insurance Group is still a smart buy after its big run, or if most of the upside is already priced in, you are not alone. That is exactly what we are going to unpack here. The stock has climbed 4.5% over the last week, 24.1% year to date, and 214.9% over five years. This naturally raises the question of whether the current price around $135.3 still offers attractive value. Recent headlines have focused on Hartford strengthening its position in commercial...

Wondering if Principal Financial Group is still good value after its long run up, or if most of the upside is already priced in? Here is a breakdown of what the market might be getting right or missing about this insurer and asset manager. The stock has quietly pushed higher, gaining 2.8% over the last week, 6.5% over the past month, and 16.2% year to date, while delivering 18.4% over 1 year and 124.7% over 5 years. Those gains have come as investors have generally rewarded financials with...

Investors in Select Water Solutions (WTTR) are parsing a fresh insider move, as President and CEO John Schmitz just unloaded roughly 281,000 shares for about 3.1 million dollars, raising questions around management sentiment and timing. See our latest analysis for Select Water Solutions. That insider selling comes as the latest share price of $10.85 sits below earlier highs, with a 1 month share price return of 8.72 percent but a year to date share price return of negative 21.15 percent. At...

Carnival Corporation & (CCL) has quietly outperformed the broader cruise space over the past week, even as the stock still sits below its recent peak. That mix of momentum and lingering skepticism is where today’s opportunity starts. See our latest analysis for Carnival Corporation &. Zooming out, Carnival Corporation &’s 7 day share price return of 6.76 percent and year to date share price return of 10.44 percent come on top of a powerful 3 year total shareholder return of 226.86 percent...

S&P Global Ratings previously downgraded Cleveland-Cliffs to B+ from BB-, citing elevated leverage and a more stressed credit profile, while the company ended a low-margin slab supply contract with ArcelorMittal that is expected to add about US$500 million of annual EBITDA through higher-priced U.S. slab sales. Together, the rating downgrade and contract exit highlight a trade-off between higher anticipated profitability and increased balance sheet risk that could influence how investors...

Argan, Inc. recently declared a regular quarterly cash dividend of US$0.50 per share, payable on January 30, 2026, to stockholders of record as of January 22, 2026. This dividend decision, alongside management’s emphasis on solid project execution, a healthy opportunity pipeline and disciplined M&A, highlights the company’s confidence in its long-term business outlook. Now we’ll examine how Argan’s new US$0.50 quarterly dividend and management’s upbeat comments influence the company’s...

On December 8, 2025, Coca-Cola Consolidated, Inc. entered into two senior unsecured term loan facilities totaling US$1.35 billion, maturing in 2028 and 2030, to refinance a US$1.20 billion bridge loan and support general corporate purposes. The new financing, with interest rates tied to Term SOFR or a base rate and governed by cash flow and leverage covenants, materially reshapes the company’s balance sheet flexibility and potential capital allocation options. We’ll now examine how this...

Earlier this week, Fitch Ratings affirmed Omega Healthcare Investors’ Long-Term Issuer Default Rating at ‘BBB-’ with a Stable Outlook, highlighting its improving operations, low leverage, and ongoing access to capital despite lingering uncertainty in the skilled nursing sector. The affirmation underscores how demographic support and portfolio improvements are helping Omega maintain credit stability even as sector-level risks persist. We’ll now examine how Fitch’s reaffirmed ‘BBB-’ rating and...

Royal Gold (RGLD) just delivered record third quarter 2025 revenue and cash flow, fueled by the Mount Milligan mine life extension, Fourmile exploration progress, and newly closed Sandstorm Gold and Horizon Copper acquisitions. See our latest analysis for Royal Gold. The market seems to be buying into that growth story, with Royal Gold’s share price up 17.72% over the past month and a strong year to date share price return of 62.59 percent. Longer term total shareholder returns above 100...

Palo Alto Networks (PANW) just landed a multiyear U.S. General Services Administration OneGov deal, giving federal agencies discounted access to its AI security and cloud platforms while shareholders backed fresh incentives and board continuity. See our latest analysis for Palo Alto Networks. Even with the GSA OneGov win and a steady drumbeat of AI security headlines, Palo Alto Networks’ 30 day share price return of minus 6.61 percent and modest year to date share price gain of 6.06 percent...

Hecla Mining’s recent presentation at Scotiabank’s 27th Annual Mining Conference in Toronto came amid its planned addition to the S&P MidCap 400 Index on December 22, 2025, and record-high silver prices supporting its core operations. Together with record quarterly revenue, tighter production guidance, and fresh permits for Nevada exploration, these developments are reshaping how investors view Hecla’s growth pipeline and market profile. We’ll now examine how Hecla’s upcoming S&P MidCap 400...

If you are wondering whether Alexandria Real Estate Equities is a beaten down bargain or a value trap, you are in the right place to unpack what the current share price is really telling us. The stock has inched up 2.6% over the last week even after falling 10.8% over the past month and sliding around 52% year to date, so something has clearly shifted in how the market is reassessing its risk and reward profile. Recent headlines have focused on how life sciences office demand is evolving and...

Earlier this week, Triumph Financial announced that BlueGrace Logistics joined the Triumph Network, improving automation, visibility, and flexible payment options for carriers and factoring partners across the freight ecosystem.

Atlanticus Holdings Corporation reported that on December 4, 2025, its Mercury subsidiaries refinanced an existing US$750,000,000 term securitization with three-year bonds that offer improved structural features and delivered an immediate coupon rate reduction of more than 200 basis points compared with the prior bonds. Management highlighted that the refinancing meaningfully lowers funding costs for credit products aimed at consumers with less-than-perfect credit histories, while also...

UnitedHealth Group (UNH) is in the spotlight after a sweeping leadership shake up, the return of former CEO Stephen Hemsley, and the suspension of its 2025 outlook, all occurring amid rising medical costs and Department of Justice scrutiny. See our latest analysis for UnitedHealth Group. After months of pressure from rising medical costs, regulatory noise, and leadership upheaval, UnitedHealth Group’s recent 1 month share price return of 6.21% looks more like a tentative rebound than a trend...

Mitek Systems (MITK) just released fresh earnings and 2025 guidance, and the headline is a mixed picture: steady revenue growth with sharply higher full-year profit, but a weaker quarterly bottom line. See our latest analysis for Mitek Systems. The earnings update seems to have reminded investors of Mitek’s steady progress, with the 1 month share price return of 12.15% lifting the latest share price to $10.06, even as the 5 year total shareholder return remains deeply negative and longer term...

Earlier this month, Zeta Global Holdings took part in the 14th Annual ROTH Deer Valley Event in Utah, with its CFO and investor relations leaders outlining the company's latest operational and financial updates to institutional investors. Ahead of and around this event, Manatuck Hill Partners lifted its stake to 705,000 shares valued at US$14.00 million, underscoring growing institutional interest in Zeta Global’s ability to convert product traction and revenue growth into stronger cash...